113 related articles for article (PubMed ID: 24716915)
1. Asparagus racemosus leaf extract inhibits growth of UOK 146 renal cell carcinoma cell line: simultaneous oncogenic PRCCTFE3 fusion transcript inhibition and apoptosis independent cell death.
Verma SP; Tripathi VC; Das P
Asian Pac J Cancer Prev; 2014; 15(5):1937-41. PubMed ID: 24716915
[TBL] [Abstract][Full Text] [Related]
2. PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.
Xiong L; Chen X; Liu N; Wang Z; Miao B; Gan W; Li D; Guo H
PLoS One; 2017; 12(9):e0185337. PubMed ID: 28949976
[TBL] [Abstract][Full Text] [Related]
3. PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma.
Wang B; Yin X; Gan W; Pan F; Li S; Xiang Z; Han X; Li D
Autophagy; 2021 Sep; 17(9):2475-2493. PubMed ID: 33019842
[TBL] [Abstract][Full Text] [Related]
4. Exploring G-quadruplex structure in PRCC-TFE3 fusion oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC).
Neha N; Das P
J Biotechnol; 2024 Jul; 390():39-49. PubMed ID: 38740306
[TBL] [Abstract][Full Text] [Related]
5. Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes.
Weterman MA; van Groningen JJ; den Hartog A; Geurts van Kessel A
Oncogene; 2001 Mar; 20(12):1414-24. PubMed ID: 11313885
[TBL] [Abstract][Full Text] [Related]
6. The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
Medendorp K; van Groningen JJ; Vreede L; Hetterschijt L; Brugmans L; van den Hurk WH; van Kessel AG
Exp Cell Res; 2009 Aug; 315(14):2399-409. PubMed ID: 19422821
[TBL] [Abstract][Full Text] [Related]
7. PRCC-TFE3 regulates migration and invasion of translocation renal cell carcinomas via activation of Drp1-dependent mitochondrial fission.
Wang B; Gan W; Han X; Li D
Cell Biol Int; 2020 Aug; 44(8):1727-1733. PubMed ID: 32339358
[TBL] [Abstract][Full Text] [Related]
8. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.
Skalsky YM; Ajuh PM; Parker C; Lamond AI; Goodwin G; Cooper CS
Oncogene; 2001 Jan; 20(2):178-87. PubMed ID: 11313942
[TBL] [Abstract][Full Text] [Related]
9. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
10. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins.
Weterman MJ; van Groningen JJ; Jansen A; van Kessel AG
Oncogene; 2000 Jan; 19(1):69-74. PubMed ID: 10644981
[TBL] [Abstract][Full Text] [Related]
11. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.
Xia QY; Wang XT; Ye SB; Wang X; Li R; Shi SS; Fang R; Zhang RS; Ma HH; Lu ZF; Shen Q; Bao W; Zhou XJ; Rao Q
Histopathology; 2018 Apr; 72(5):786-794. PubMed ID: 29148086
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
[TBL] [Abstract][Full Text] [Related]
13. Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line.
Verma SP; Das P
In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):736-742. PubMed ID: 30324243
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents.
Cao C; Lan X; Shang B; Jiang W; Guo L; Zheng S; Bi X; Zhou A; Sun Z; Shou J
Clin Transl Oncol; 2022 Jul; 24(7):1333-1346. PubMed ID: 35118587
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.
Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH
Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
LaGrange CA; Lele SM; Strup SE
Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124
[TBL] [Abstract][Full Text] [Related]
17. Role of PSF-TFE3 oncoprotein in the development of papillary renal cell carcinomas.
Mathur M; Samuels HH
Oncogene; 2007 Jan; 26(2):277-83. PubMed ID: 16832349
[TBL] [Abstract][Full Text] [Related]
18. PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.
Onder AM; Teomete U; Argani P; Toledano S; Zilleruelo G; Rodriguez MM
Pediatr Nephrol; 2006 Oct; 21(10):1471-5. PubMed ID: 16807766
[TBL] [Abstract][Full Text] [Related]
19. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.
Classe M; Malouf GG; Su X; Yao H; Thompson EJ; Doss DJ; Grégoire V; Lenobin J; Fantoni JC; Sudour-Bonnange H; Khayat D; Aubert S; Tannir NM; Leroy X
Histopathology; 2017 Jun; 70(7):1089-1097. PubMed ID: 28106924
[TBL] [Abstract][Full Text] [Related]
20. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.
Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E
Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]